Anterix Inc.
ATEX
$18.81
-$0.39-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.92M | 6.03M | 5.90M | 5.61M | 5.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.92M | 6.03M | 5.90M | 5.61M | 5.11M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.92M | 6.03M | 5.90M | 5.61M | 5.11M |
| SG&A Expenses | 46.02M | 48.78M | 49.29M | 51.41M | 51.87M |
| Depreciation & Amortization | 493.00K | 548.00K | 663.00K | 719.00K | 777.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.62M | 55.06M | 56.84M | 59.13M | 59.02M |
| Operating Income | -45.70M | -49.03M | -50.94M | -53.53M | -53.92M |
| Income Before Tax | 27.75M | -9.48M | -28.90M | -34.71M | -19.46M |
| Income Tax Expenses | -1.59M | 1.89M | 1.09M | 2.66M | 3.08M |
| Earnings from Continuing Operations | 29.33 | -11.37 | -29.99 | -37.37 | -22.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.33M | -11.37M | -29.99M | -37.37M | -22.53M |
| EBIT | -45.70M | -49.03M | -50.94M | -53.53M | -53.92M |
| EBITDA | -45.20M | -48.49M | -50.28M | -52.81M | -53.14M |
| EPS Basic | 1.58 | -0.62 | -1.62 | -2.02 | -1.22 |
| Normalized Basic EPS | -1.47 | -1.58 | -1.63 | -1.70 | -1.71 |
| EPS Diluted | 1.56 | -0.63 | -1.63 | -2.02 | -1.22 |
| Normalized Diluted EPS | -1.46 | -1.57 | -1.62 | -1.70 | -1.70 |
| Average Basic Shares Outstanding | 74.40M | 74.26M | 74.17M | 74.26M | 74.60M |
| Average Diluted Shares Outstanding | 74.78M | 74.57M | 74.34M | 74.47M | 75.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |